News & Events

Johannes R. Kratz, M.D. and Yeranuí Ledesma, M.D. are among this year's recipients of the 2017 UCSF Health Exceptional Physician Award. Dr. Kratz, now a member of the Thoracic Oncology Program and Assistant Professor in the Division of Adult Cardiothoracic Surgery, and Dr. Ledesma, a Senior Resident in General...

The Department of Surgery welcomes Johannes R. Kratz, M.D. to the faculty as Assistant Professor in the Division of Adult Cardiothoracic Surgery and member of the Thoracic Oncology Program. Dr. Kratz was a surgical research fellow in the UCSF Thoracic Oncology Laboratory from 2008-2011 where he played a key role...

Former professor Thierry Jahan, M.D ., discussed clinical data from the study, Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma, at the ESMO/IASLC European Congress on Lung Cancer in Geneva in April 2016. This is a Phase Ib trial of CRS-207...

Building on earlier retrospective validation studies , a team of Thoracic Oncology Program researchers, demonstrated in a small prospective study the clinical utility of a 14-gene expression assay in stratifying risk among non-small cell lung cancer (NSCLC) patients. In a recently published paper in the journal...

UCSF News reports on the uses of the Google Glass in the operating room and the pioneering efforts of Pierre Theodore, M.D. in deploying the technology: Cardiothoracic surgeon Pierre Theodore, MD, goes into the operating room with one main goal: getting his patient in and out of surgery safely and efficiently...

Building on their earlier work reported in The Lancet, UCSF thoracic surgeon Michael Mann, M.D. (left), and Johannes Kratz, M.D. (right) a former surgical resident in the Thoracic Oncology Lab, showed they could accurately stratify patients even with the earliest stage of lung cancer into groups at low-...

The NIH has awarded two UCF scientists, Hassan Lemjabbar-Alaoui, Ph.D and Joanna J. Phillips, M.D., Ph.D., a five-year $2.2m grant to study the clinical utility of extracellular heparan sulfate endosulfatases, or SULFs, as biomarkers for early detection of non-small cell lung cancer (NSCLC) and malignant...

A team consisting of Hassan Lemjabbar-Alaoui, Ph.D., Assistant Adjunct Professor of Surgery and principal Investigator in the Thoracic Oncology Laboratory and Alaoui Lab, and Steven Rosen, PhD, Professor and Vice-chair of the Department of Anatomy, are developing a novel treatment for lung cancer in a unique...

Edward Kim, M.D. and Pierre R. Theodore, M.D. will be among the recipients of 2011 Haile T. Debas Academy of Medical Educator's Excellence in Teaching Awards at the Academy's annual Celebration on Monday, September 19, 2011. The Haile T. Debas Academy of Medical Educators is dedicated to creating an environment...

Thierry Jahan, M.D., an Associate Professor of Medicine Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology, is one of four recipients of the 2010 UCSF Medical Center Exceptional Physician Award, an honor recognizing dedication to outstanding patient care and to the instiutions' values of...

Last October, opera singer Zheng Cao fell during a performance and had no idea why. Later, it turned out she had advanced lung cancer. Now, as a result of treatment with a new type of targeted therapy, her cancer is retreating. Personalized medicine - that is, customizing the treatment to the patient's tumor -is...

Dr. Jasleen Kukreja "is not the first surgeon to perform a minimally invasive lobectomy at UCSF, but she may be a pioneer in the two-finger clamp technique, because her predecessors are men who have a tougher time squeezing in both fingers. Last summer, she became the first doctor to be hired by UCSF to focus...

Before an overflow crowd at the UCSF Comprehensive Cancer Center, members of the Thoracic Oncology Program speak about the challenges of lung cancer and the progress that has been made in finding effective treatments and one day a cure.

Adding their own contributions to a rapidly advancing field, UCSF researchers - along with colleagues from Incyte Corporation and the University of Texas Southwestern Medical Center - have described new targets in lung cancer and evaluated a promising new drug candidate that halts growth signals in tumor cells...